Sayenza Biosciences

medical devices

About

Sayenza Bio is a leading clinical stage biotechnology company committed to improving patient lives by harnessing the regenerative power of fat, the body's largest source of stem cells, for limitless aesthetic and regenerative medicine applications. At Sayenza, our passionate, doctor-driven team unites cutting-edge scientific innovation with vast commercial expertise, propelling us towards transformative breakthroughs in healthcare. With a strong leadership team in place, extensive publications in leading journals, and top-tier KOLs signing up as early adopters, NESVF™ and Liquid Gold Graft™ are poised to become gold standards for stem cell and fat grafting applications and take a large chunk of the $6.25 billion aesthetics market.

Technologies

Gmail Google Apps Remote

Keywords

fat grafting automated fat filtration stromal vascular fraction regenerative medicine fat processing diabetic wound healing cell viability analysis tissue engineering fat grafting automation cell therapy biomedical engineering tissue regeneration point-of-care therapeutics microfluidics nanofat b2b manufacturing fat processing technology cell yield optimization automated device adipose-derived stem cells healthcare mechanical processing nesvf regenerative cell populations enrichment cell isolation cell viability clinical stage fat emulsification device regenerative cell populations

Location

5270 California Ave, Irvine, California, United States, 92617-3231

Related Companies

Companies in the same industry